These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
161 related items for PubMed ID: 9622984
1. Acute haemodynamic effects of nicorandil in patients with chronic severe regurgitant valvular lesions. Yadav R, Bhargava B, Aggarwal R, Narang R, Chopra A, Sapra R, Manchanda SC. Indian Heart J; 1998; 50(2):173-8. PubMed ID: 9622984 [Abstract] [Full Text] [Related]
2. Vasoactive drugs in chronic regurgitant lesions of the mitral and aortic valves. Levine HJ, Gaasch WH. J Am Coll Cardiol; 1996 Nov 01; 28(5):1083-91. PubMed ID: 8890799 [Abstract] [Full Text] [Related]
3. Clinical profile of nicorandil: an overview of its hemodynamic properties and therapeutic efficacy. Krumenacker M, Roland E. J Cardiovasc Pharmacol; 1992 Nov 01; 20 Suppl 3():S93-102. PubMed ID: 1282184 [Abstract] [Full Text] [Related]
4. [The best of valvular heart disease in 2006]. de Gevigney G, Groupe de travail sur les valvulopathies de la Societe francaise de cardiologi. Arch Mal Coeur Vaiss; 2007 Jan 01; 100 Spec No 1():19-28. PubMed ID: 17405561 [Abstract] [Full Text] [Related]
5. [Successful treatment of intraoperative myocardial ischemia with nicorandil]. Kawamura S, Hayashida M, Orii R, Sawamura S, Komatsu K, Ito N, Kuzumi E, Hanaoka K. Masui; 1997 Apr 01; 46(4):531-7. PubMed ID: 9128027 [Abstract] [Full Text] [Related]
6. Acute hemodynamic effects of nicorandil in patients with primary pulmonary arterial hypertension. Yadav R, Anandaraja S, Bhargava B, Jindal R, Goswami KC. Indian Heart J; 2005 Apr 01; 57(6):666-9. PubMed ID: 16521635 [Abstract] [Full Text] [Related]
7. [Chronic aortic and mitral valve regurgitation. Effects of isosorbide dinitrate on systolic function and passive elastic properties of the left ventricle (author's transl)]. Herreman F, Cosma H, Degeorges M. Nouv Presse Med; 1982 Jun 10; 11(27):2095-100. PubMed ID: 7110972 [Abstract] [Full Text] [Related]
8. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery. Schroth M, Plank C, Meissner U, Eberle KP, Weyand M, Cesnjevar R, Dötsch J, Rascher W. Pediatrics; 2006 Jul 10; 118(1):e76-84. PubMed ID: 16751617 [Abstract] [Full Text] [Related]
9. Acute severe mitral regurgitation during first attacks of rheumatic fever: clinical spectrum, mechanisms and prognostic factors. Kamblock J, N'Guyen L, Pagis B, Costes P, Le Goanvic C, Lionet P, Maheu B, Papouin G. J Heart Valve Dis; 2005 Jul 10; 14(4):440-6. PubMed ID: 16116868 [Abstract] [Full Text] [Related]
10. Beneficial effects of nicorandil versus enalapril in chronic rheumatic severe mitral regurgitation: six months follow up echocardiographic study. Gupta DK, Kapoor A, Garg N, Tewari S, Sinha N. J Heart Valve Dis; 2001 Mar 10; 10(2):158-65. PubMed ID: 11297201 [Abstract] [Full Text] [Related]
11. Medical treatment of chronic valvular regurgitation. Schön HR. J Heart Valve Dis; 1995 Oct 10; 4 Suppl 2():S170-4. PubMed ID: 8563994 [No Abstract] [Full Text] [Related]
12. Hemodynamic action of nicorandil in chronic congestive heart failure. Solal AC, Jaeger P, Bouthier J, Juliard JM, Dahan M, Gourgon R. Am J Cardiol; 1989 Jun 20; 63(21):44J-48J. PubMed ID: 2525325 [Abstract] [Full Text] [Related]
13. Dose-related haemodynamic effects and pharmacokinetics of oral nicorandil in patients evaluated for chest pain. Arnold JM, Kowey PR, Wolf DL, Jungbluth GL, Hearron AE, Luderer JR. Int J Cardiol; 1994 May 20; 44(3):203-15. PubMed ID: 8077066 [Abstract] [Full Text] [Related]
14. Pilot study to assess the influence of beta-blockade on mitral regurgitant volume and left ventricular work in degenerative mitral valve disease. Stewart RA, Raffel OC, Kerr AJ, Gabriel R, Zeng I, Young AA, Cowan BR. Circulation; 2008 Sep 02; 118(10):1041-6. PubMed ID: 18725484 [Abstract] [Full Text] [Related]
15. Hydralazine in heart failure. Chatterjee K. Herz; 1983 Aug 02; 8(4):187-98. PubMed ID: 6413340 [Abstract] [Full Text] [Related]
16. New insights in the pathophysiology of mitral and aortic regurgitation in pediatric age: role of angiotensin-converting enzyme inhibitor therapy. Pisacane C, Pacileo G, Santoro G, Sarubbi B, Iacono C, Russo MG, Calabrò R. Ital Heart J; 2001 Feb 02; 2(2):100-6. PubMed ID: 11256536 [Abstract] [Full Text] [Related]
17. Systemic and coronary hemodynamic effects of JTV-506, a novel potassium channel opener, in conscious dogs: comparison with cromakalim and nicorandil. Zhang S, Sakai K, Hasuo H, Furuta K, Ureshino H, Shibata O, Sumikawa K. Res Commun Mol Pathol Pharmacol; 1999 Feb 02; 105(1-2):115-27. PubMed ID: 10850375 [Abstract] [Full Text] [Related]
18. [Long-term results of mitral-aortic valve replacement in 1,154 patients with rheumatic valvular disease]. Zhang BR, Zou LJ, Xu ZY, Mei J, Wang ZN, Sun DH, Yu WY, Wang LC. Zhonghua Wai Ke Za Zhi; 2003 Apr 02; 41(4):243-6. PubMed ID: 12882662 [Abstract] [Full Text] [Related]
19. [Hemodynamic effects of phentolamine in acute and chronic mitral insufficiency after myocardial infarction]. Renard M, Jacobs P, Sobkowicz-Wozniak B, Kostucki W, Bernard R. Arch Mal Coeur Vaiss; 1985 Jan 02; 78(1):37-43. PubMed ID: 3919678 [Abstract] [Full Text] [Related]
20. [Cardioprotective effects of K(ATP) channel opener nicorandil during ischemia/ reperfusion in dogs]. Feng L, Qiu J, Ma J, Huang XB, Cha DG, Bin JP. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2005 Mar 02; 17(3):157-60. PubMed ID: 15760526 [Abstract] [Full Text] [Related] Page: [Next] [New Search]